Why the study?
Identifying a possible genetic background responsible for high-risk profiles and determining which myocarditis patients require genetic testing remains an uncovered clinical challenge.
Identifying genetic defects in myocarditis patients could improve risk stratification and management by detecting those prone to long-lasting cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support genetic testing for myocarditis risk stratification; leaves open need for prospective validation before adoption.
The latest research highlights the possible prognostic role of some pathogenic mutations that could create a vulnerable myocardium prone to myocardial inflammation and also to the development of a long-lasting cardiomyopathy. The identification of these genetic defects and of myocarditis patients requiring genetic testing is emerging as a challenge for the future. In fact, identifying a possible genetic background responsible for a particularly high-risk profile could be of extreme importance in improving management of myocarditis. This and many other aspects in the genetics of myocarditis remain uncovered, and further studies are expected based to refine our daily clinical practice.
No takes yet. Share an insight, caveat, or question.
Baggio et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: